Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation

Abstract

The TRK-T3 oncoprotein, isolated from a human papillary thyroid tumor, arises from the fusion between the N-terminal domain of the TFG gene and the tyrosine kinase domain of the NTRK1 receptor. The 68 kDa TRK-T3 oncoprotein displays a constitutive tyrosine kinase activity resulting in its capability to transform NIH3T3 cells. The TFG portion of TRK-T3 contains a coiled-coil domain, which mediates protein oligomerization essential for the oncogene constitutive activation, and several consensus sites for protein interaction. In this study, we investigate the role of TFG sequences outside the coiled-coil domain on TRK-T3 activation, We constructed four mutants carrying different deletions of TFG sequences and expressed them in mammalian cells. By performing biochemical and biological assays we demonstrated that all the deleted regions are required for TRK-T3 activation, as they are involved in different mechanisms such as protein processing, formation of stable and/or functional complexes, and possible interaction with other proteins. By constructing site-specific mutants, we demonstrated a crucial role for a PB1 domain and a considerable contribution of an SH2-binding motif in TRK-T3 oncogenic activation. This work establishes an important role for TFG sequences outside the coiled-coil domain in the activation of the thyroid TRK-T3 oncogene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Borrello MG, Pelicci G, Arighi E, De Filippis L, Greco A, Bongarzone I, Rizzetti MG, Pelicci PG and Pierotti MA . (1994). Oncogene, 9, 1661–1668.

  • Byrd DA, Sweet DJ, Pante' N, Konstantinov KN, Guan T, Shapire ACS, Mitchell PJ, Cooper CS, Aebi U and Gerace L . (1994). J. Cell Biol., 127, 1515–1526.

  • Canu N, Possenti R, Rinaldi AM, Trani E and Levi A . (1997). J. Neurochem., 68, 1390–1399.

  • Durick K, Yao VJ, Borrello MG, Bongarzone I, Pierotti MA and Taylor SS . (1995). J. Biol. Chem., 270, 24642–24645.

  • Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T and Kasuga M . (1996). Mol. Cell Biol., 16, 6887–6899.

  • Greco A, Fusetti L, Miranda C, Villa R, Zanotti S, Pagliardini S and Pierotti MA . (1998). Oncogene, 16, 809–816.

  • Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M and Pierotti MA . (1995). Mol. Cell. Biol., 15, 6118–6127.

  • Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara FF, Bonci D, Nervi C and Pelicci PG . (1999). Oncogene, 18, 6313–6321.

  • Ito T, Matsui Y, Ago T, Ota K and Sumimoto H . (2001). EMBOJ., 20, 3938–3946.

  • Johnston JA, Ward CL and Kopito RR . (1998). J. Cell. Biol., 143, 1883–1898.

  • Kaplan DR, Martin-Zanca D and Parada LF . (1991). Nature, 350, 158–160.

  • Klein R, Jing S, Nanduri V, O'Rourke E and Barbacid M . (1991). Cell, 65, 189–197.

  • Lupas A . (1996). Trends Biochem. Sci., 21, 375–382.

  • Lupas A, Van Dyke M and Stock J . (1991). Science, 252, 1162–1164.

  • Martin-Zanca D, Hughes SH and Barbacid M . (1986). Nature, 319, 743–748.

  • Matthews JM, Young TF, Tucker SP and Mackay JP . (2001). J. Virol., 74, 5911–5920.

  • McWhirter JR, Galasso DL and Wang JY . (1993). Mol. Cell. Biol., 13, 7587–7595.

  • Mencinger M and Aman P . (1999). Biochem. Biophys. Res. Commun., 257, 67–73.

  • Mencinger M, Panagopoulos I, Andreasson P, Lassen C, Mitelman F and Aman P . (1997). Genomics, 41, 372–331.

  • Miranda C, Greco A, Miele C, Pierotti MA and Van Obberghen E . (2001). J. Cell. Physiol, 186, 35–46.

  • Monaco C, Visconti R, Barone MV, Pierantoni GM, Berlingieri MT, De Lorenzo C, Mineo A, Vecchio G, Fusco A and Santoro M . (2001). Oncogene, 20, 599–608.

  • Pierotti MA, Bongarzone I, Borrello MG, Greco A, Pilotti S and Sozzi G . (1996). Genes Chromosones Cancer, 16, 1–14.

  • Possenti R, Di Rocco G, Nasi S and Levi A . (1992). Proc. Natl. Acad. Sci. USA, 89, 3815–3819.

  • Roccato E, Miranda C, Ranzi V, Gishizky ML, Pierotti MA and Greco A . (2002). Br. J. Cancer, 87, 645–653.

  • Rodrigues GA and Park M . (1993). Mol. Cell. Biol., 13, 6711–6722.

  • Rodrigues GA and Park M . (1994). Curr. Opin. Genet. Develop., 13, 6711–6722.

  • Terasawa H, Noda Y, Ito T, Hatanaka H, Ichikawa S, Ogura K, Sumimoto H and Inagaki F . (2001). Embo J., 20, 3947–3956.

  • Tong Q, Xing S and Jhiang SM . (1997). J. Biol. Chem., 272, 9043–9047.

Download references

Acknowledgements

We thank Miss Cristina Mazzadi for secretarial assistance. We thank Prof. Marchisio for advises on immunofluorescence procedure, Elena Luison for chromatography experiments and Dr Cristiano Rumio for immunofluorescence analysis by confocal microscopy. This work was supported by AIRC (Italian Association for Cancer Research).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela Greco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roccato, E., Pagliardini, S., Cleris, L. et al. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation. Oncogene 22, 807–818 (2003). https://doi.org/10.1038/sj.onc.1206189

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206189

Keywords

This article is cited by

Search

Quick links